'Miracle' weight-loss drugs could have reduced health disparities: Instead they got worse
The American Heart Association calls them "game changers."
Apr 22, 2024
0
1
The American Heart Association calls them "game changers."
Apr 22, 2024
0
1
Initially, diabetes drugs like Ozempic and Wegovy showed promise in weight loss and have subsequently been marketed and widely used for weight loss. Now these medications are showing promise as a possible treatment for multiple ...
Apr 15, 2024
0
0
For people struggling with both diabetes and a common type of heart failure, the weight-loss drug Wegovy may do more for their health than help them shed pounds, new research suggests.
Apr 9, 2024
0
2
Some health care professionals are growing concerned that amid the recent rush for the new highly effective, anti-obesity medications, patients are losing muscle as well as fat, which carries the risk that frailty will accompany ...
Mar 19, 2024
0
1
A clinical trial led by University of Cincinnati researchers at the Lindner Center of HOPE found a drug was safe and effective for weight loss for patients with stable bipolar disorder.
Mar 4, 2024
0
0
Research targeting the insulin-inhibitory receptor, or inceptor, unveils promising avenues for beta cell protection, offering hope for causal diabetes therapy.
Feb 28, 2024
0
15
For nearly a year, we have been debating weight loss drugs like Wegovy, Zepbound, Saxenda and similar products and what happens when people stop taking them. Are they able to maintain weight loss? A new Danish study sheds ...
Feb 20, 2024
0
29
Add depression to the growing list of chronic diseases that obesity medicines might alleviate. Signs of improved mental health are showing up in the health records of people who take the broader class of medicines known as ...
Feb 19, 2024
0
34
As public health experts search for new ways to tackle the obesity crisis, a Loughborough University study has found that patients would welcome support from their dentist on weight management.
Feb 14, 2024
0
1
Dietary supplements are a big business. The industry made almost US$39 billion in revenue in 2022, and with very little regulation and oversight, it stands to keep growing.
Feb 6, 2024
0
12